Kestra Medical Technologies' ASSURE WCD shows strong safety, effectiveness in real-world study.

• Kestra Medical Technologies releases ACE-PAS study results at AHA 2025 • ASSURE WCD shows strong safety and effectiveness in real-world practice • Study confirms risk of life-threatening arrhythmias in patients with reduced cardiac function • ACE-PAS is largest prospective real-world study of wearable defibrillators to date • Results provide contemporary data on ASSURE WCD performance in routine care • Jeanne E. Poole, MD, praises ACE-PAS as providing robust real-world evidence.